- Home
- GPRK vs EBS Comparison
GPRK vs EBS Comparison
Compare GPRK & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRK
- EBS
- Stock Information
- Founded
- GPRK 2002
- EBS 1998
- Country
- GPRK Colombia
- EBS United States
- Employees
- GPRK N/A
- EBS N/A
- Industry
- GPRK Oil & Gas Production
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- GPRK Energy
- EBS Health Care
- Exchange
- GPRK Nasdaq
- EBS Nasdaq
- Market Cap
- GPRK 335.7M
- EBS 359.3M
- IPO Year
- GPRK N/A
- EBS 2006
- Fundamental
- Price
- GPRK $6.35
- EBS $7.59
- Analyst Decision
- GPRK Buy
- EBS Strong Buy
- Analyst Count
- GPRK 1
- EBS 3
- Target Price
- GPRK $11.00
- EBS $14.33
- AVG Volume (30 Days)
- GPRK 704.3K
- EBS 1.2M
- Earning Date
- GPRK 11-05-2025
- EBS 11-05-2025
- Dividend Yield
- GPRK 9.29%
- EBS N/A
- EPS Growth
- GPRK N/A
- EBS N/A
- EPS
- GPRK 0.81
- EBS 2.53
- Revenue
- GPRK $560,354,000.00
- EBS $851,600,000.00
- Revenue This Year
- GPRK N/A
- EBS N/A
- Revenue Next Year
- GPRK N/A
- EBS $19.24
- P/E Ratio
- GPRK $7.85
- EBS $3.00
- Revenue Growth
- GPRK N/A
- EBS N/A
- 52 Week Low
- GPRK $5.66
- EBS $4.02
- 52 Week High
- GPRK $11.72
- EBS $12.73
- Technical
- Relative Strength Index (RSI)
- GPRK 45.00
- EBS 41.67
- Support Level
- GPRK $6.18
- EBS $8.16
- Resistance Level
- GPRK $6.69
- EBS $8.62
- Average True Range (ATR)
- GPRK 0.23
- EBS 0.39
- MACD
- GPRK 0.00
- EBS -0.22
- Stochastic Oscillator
- GPRK 30.00
- EBS 3.72
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.